文献速递胸部CT

基于CT的深度学习模型改善临床I期肺癌无病生存预测:一项真实世界多中心研究

CT-based deep learning model for improved disease-free survival prediction in clinical stage I lung cancer: a real-world multicenter study.
PubMed 文献 · Eur Radiol · 2025-06-12

该研究基于治疗前CT图像开发三维卷积神经网络深度学习模型,用于预测接受手术切除的临床I期非小细胞肺癌患者无病生存,并在接受立体定向体部放疗的患者中进行外部验证;手术队列内部测试集C指数为0.85,优于临床模型0.76,SBRT队列中高风险组5年无病生存率34.7%低于低风险组77.4%(p<0.01)。

要点

  • 基于治疗前CT的深度学习模型可预测临床I期肺癌术后无病生存,内部测试集C指数0.85。
  • SBRT外部验证队列中,深度学习模型划分的高风险组5年无病生存率34.7%,低风险组77.4%(p<0.01)。
  • 深度学习评分在手术和SBRT两个队列中均为无病生存的独立预测因子(p<0.01)。

核心结论

  • 基于CT的深度学习模型改善了临床I期肺癌患者的无病生存预测,可识别复发和转移高风险人群,以指导临床决策。

研究设计与样本

  • 回顾性队列研究,纳入2489例2015-2017年接受手术治疗的临床I期非小细胞肺癌患者开发深度学习无病生存预测模型,采用三维卷积神经网络从CT图像提取肿瘤特征,并通过多因素Cox回归构建临床模型进行对比。

诊断标准与关键数值

  • 深度学习模型在手术队列内部测试集预测无病生存的C指数为0.85(95%CI:0.80-0.89),显著优于临床模型的C指数0.76。

临床应用与阅片要点

  • 基于治疗前CT的深度学习模型可用于临床I期肺癌手术或SBRT患者的无病生存预测和风险分层,深度学习评分为无病生存的独立预测因子(p<0.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop a deep learning (DL) model for predicting disease-free survival (DFS) in clinical stage I lung cancer patients who underwent surgical resection using pre-treatment CT images, and further validate it in patients receiving stereotactic body radiation therapy (SBRT).

MATERIALS AND METHODS: A retrospective cohort of 2489 clinical stage I non-small cell lung cancer (NSCLC) patients treated with operation (2015-2017) was enrolled to develop a DL-based DFS prediction model. Tumor features were extracted from CT images using a three-dimensional convolutional neural network. External validation was performed on 248 clinical stage I patients receiving SBRT from two hospitals. A clinical model was constructed by multivariable Cox regression for comparison. Model performance was evaluated with Harrell's concordance index (C-index), which measures the model's ability to correctly rank survival times by comparing all possible pairs of subjects.

RESULTS: In the surgical cohort, the DL model effectively predicted DFS with a C-index of 0.85 (95% CI: 0.80-0.89) in the internal testing set, significantly outperforming the clinical model (C-index: 0.76). Based on the DL model, 68 patients in the SBRT cohort identified as high-risk had significantly worse DFS compared to the low-risk group (p < 0.01, 5-year DFS rate: 34.7% vs 77.4%). The DL-score was demonstrated to be an independent predictor of DFS in both cohorts (p < 0.01).

CONCLUSION: The CT-based DL model improved DFS prediction in clinical stage I lung cancer patients, identifying populations at high risk of recurrence and metastasis to guide clinical decision-making.

KEY POINTS: Question The recurrence or metastasis rate of early-stage lung cancer remains high and varies among patients following radical treatments such as surgery or SBRT. Findings This CT-based DL model successfully predicted DFS and stratified varying disease risks in clinical stage I lung cancer patients undergoing surgery or SBRT. Clinical relevance The CT-based DL model is a reliable predictive tool for the prognosis of early-stage lung cancer. Its accurate risk stratification assists clinicians in identifying specific patients for personalized clinical decision making.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Fu Y, Hou R, Qian L, et al. CT-based deep learning model for improved disease-free survival prediction in clinical stage I lung cancer: a real-world multicenter study. Eur Radiol. 2025. PMID: 40506642. doi:10.1007/s00330-025-11682-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。